Loading...
The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
BACKGROUND: The Food and Drug Administration has approved several pharmacotherapies for the treatment of obesity. This study assesses the cost‐effectiveness of six pharmacotherapies and lifestyle intervention for people with mild obesity (body mass indices [BMIs] 30 to 35). METHODS: A microsimulatio...
Saved in:
| Published in: | Obes Sci Pract |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7156872/ https://ncbi.nlm.nih.gov/pubmed/32313674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/osp4.390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|